LVTX — LAVA Therapeutics NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Annual balance sheet for LAVA Therapeutics NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	10-K	10-K
Standards:	IFRS	IFRS	IFRS	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15.8	133	133	95.6	76.6
Net Total Accounts Receivable
Net Total Receivables	1.48	0.734	3.25	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18.2	137	141	98.9	79.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.5	1.95	2.08	2.46	1.44
Other Long Term Assets
Total Assets	20.5	139	143	102	80.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.33	11.2	22	14.9	18
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.9	20.9	57.4	50.3	53.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	7.62	118	86	51.4	27.7
Total Liabilities & Shareholders' Equity	20.5	139	143	102	80.8
Total Common Shares Outstanding